Get the Stockscreener App
2.26
5.83%
-0.14
After Hours:
2.34
0.08
+3.54%
Connect Biopharma Holdings Ltd stock is traded at $2.26, with a volume of 64,285.
It is down -5.83% in the last 24 hours and down -5.83% over the past month.
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
See More
Previous Close:
$2.40
Open:
$2.39
24h Volume:
64,285
Relative Volume:
0.24
Market Cap:
$126.34M
Revenue:
-
Net Income/Loss:
$-21.38M
P/E Ratio:
-5.7949
EPS:
-0.39
Net Cash Flow:
$-25.19M
1W Performance:
-16.30%
1M Performance:
-5.83%
6M Performance:
+93.28%
1Y Performance:
+94.83%
1-Day Range:
$2.26
$2.4449
1-Week Range:
$2.26
$2.83
52-Week Range:
$0.51
$3.28
Connect Biopharma Holdings Ltd Stock (CNTB) Company Profile
Name
Connect Biopharma Holdings Ltd
Sector
Industry
Phone
858-727-1040
Address
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Compare CNTB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd
|
2.26 | 134.17M | 0 | -21.38M | -25.19M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Connect Biopharma Holdings Ltd Stock (CNTB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-01-25 | Initiated | Lake Street | Buy |
| Oct-31-25 | Initiated | BTIG Research | Buy |
| Jun-12-25 | Initiated | H.C. Wainwright | Buy |
| Mar-04-24 | Initiated | H.C. Wainwright | Buy |
| Apr-13-21 | Initiated | Jefferies | Buy |
| Apr-13-21 | Initiated | Piper Sandler | Overweight |
| Apr-13-21 | Initiated | SVB Leerink | Outperform |
View All
Connect Biopharma Holdings Ltd Stock (CNTB) Latest News
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Aptevo Therapeutics (APVO) Stock Price, Quote, News & History - Benzinga
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Newport Daily News
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Connect Biopharma Announces Board Resignation - TradingView — Track All Markets
Discovering Connect Biopharma Holdings And 2 Other Promising Penny Stocks - simplywall.st
Connect Biopharma (NASDAQ:CNTB) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Connect Biopharma Hldgs (CNTB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Connect Biopharma Holdings Limited's (NASDAQ:CNTB) largest shareholders are private equity firms with 39% ownership, individual investors own 22% - Yahoo Finance
Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3 - Hillsdale Daily News
Analyzing Connect Biopharma (NASDAQ:CNTB) and Axsome Therapeutics (NASDAQ:AXSM) - Defense World
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives $8.50 Average Price Target from Analysts - Defense World
Connect Biopharma (NASDAQ:CNTB) Now Covered by Analysts at Lake Street Capital - MarketBeat
Check Out Connect Biopharma Holdings Ltd (CNTB)’s Trade Data Rather Than the Analysts’ Views - Setenews
Connect Biopharma (NASDAQ:CNTB) Research Coverage Started at Lake Street Capital - Defense World
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Lake Street Initiates Coverage on Connect Biopharma (CNTB) with 'Buy' Rating | CNTB Stock News - GuruFocus
CASI Pharmaceuticals Announces Changes in Board Governance - Investing News Network
Shareholder Panacea Innovation Ltd Files To Sell 2,000,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
Taking on analysts’ expectations and winning: Connect Biopharma Holdings Ltd (CNTB) - Setenews
Connect Biopharma Management to Participate in 8th Annual Evercore Healthcare Conference on December 2, 2025 - Quiver Quantitative
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference - The Manila Times
Shareholder Zheng-Wu Family Trust Files To Sell 650,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
Connect Biopharma Holdings Limited (CNTB) -11.98% in Normal Trading: Shares Decline Amidst Recent Developments - Stocks Telegraph
CASI Pharmaceuticals (NASDAQ: CASI) appoints James Huang Non-Executive Chairman - Stock Titan
Owner BioFortune Inc Files To Sell 500,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
HC Wainwright Issues Pessimistic Estimate for CNTB Earnings - Defense World
Connect Biopharma Reports Significant Loss Amid Development Efforts - TipRanks
Perhaps timely catching Lazydays Holdings Inc (GORV) would be a good idea - setenews.com
The time has not yet come to remove your chips from the table: Connect Biopharma Holdings Ltd (CNTB) - Setenews
FY2025 EPS Forecast for Connect Biopharma Lowered by Analyst - MarketBeat
Connect Biopharma’s (CNTB) “Buy” Rating Reiterated at BTIG Research - Defense World
Araptus launches affordable Black Friday web package for small businesses at $900 setup + $100/month - St. Cloud Times
Connect Biopharma's (CNTB) Buy Rating Reiterated at BTIG Research - MarketBeat
Connect Biopharma (NASDAQ:CNTB) Announces Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat
BTIG Reiterates Buy Rating for CNTB with $10 Price Target | CNTB Stock News - GuruFocus
Connect Biopharma Holdings Ltd SEC 10-Q Report - TradingView
[10-Q] Connect Biopharma Holdings Ltd Quarterly Earnings Report | CNTB SEC FilingForm 10-Q - Stock Titan
Connect Biopharma Holdings Ltd Stock (CNTB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):